Search results for "Cluster headache"

showing 7 items of 27 documents

O047. The sound-induced flash illusions reveal visual cortex hyperexcitability in cluster headache

2015

Objectives Pathophysiology of cluster headache (CH) is not wellknown. Although posterior hypothalamus has been suggested to play a pivotal role, evidence exists of a more diffuse involvement of the central nervous system including brainstem and cerebral cortex. In this regard, we recently observed increased motor cortical excitability in episodic CH patients both outside and inside bout [1]. The sound-induced flash illusions (SIFI) represent an example of multisensory integration, and provide a tool to indirectly explore the excitability state of the visual cortex [2]. SIFI are classified as “fission” and “fusion” illusions. When one visual stimulus (flash) is accompanied by two or more aud…

genetic structuresbusiness.industryCluster headachemedia_common.quotation_subjectCentral nervous systemcluster headacheIllusionClinical NeurologyMultisensory integrationGeneral MedicineStimulus (physiology)medicine.diseasemedicine.anatomical_structureVisual cortexAnesthesiology and Pain MedicineCerebral cortexTMSAnesthesiology and Pain Medicine; Neurology (clinical); cluster headache; TMSmedicineOral PresentationNeurology (clinical)BrainstembusinessNeurosciencemedia_commonThe Journal of Headache and Pain
researchProduct

Technical and surgical aspects of the sphenopalatine ganglion (SPG) microstimulator insertion procedure

2015

Cluster headache (CH) is a debilitating, severe form of headache. A novel non-systemic therapy has been developed that produces therapeutic electrical stimulation to the sphenopalatine ganglion (SPG). A transoral surgical technique for inserting the Pulsante SPG Microstimulator into the pterygopalatine fossa (PPF) is presented herein. Technical aspects include detailed descriptions of the preoperative planning using computed tomography or cone beam computed tomography scans for presurgical digital microstimulator insertion into the patient specific anatomy and intraoperative verification of microstimulator placement. Surgical aspects include techniques to insert the microstimulator into the…

medicine.medical_specialtyCone beam computed tomographymedicine.medical_treatmentPterygopalatine FossaCluster HeadacheElectric Stimulation TherapyRadiography Interventional03 medical and health sciences0302 clinical medicinemedicineHumansPain ManagementInsertion procedure030212 general & internal medicineDental implantNeurostimulationsphenopalatine ganglionPterygopalatine fossaPain Measurementbusiness.industryCluster headachepterygopalatine fossacluster headacheGanglia ParasympatheticPerioperativeEquipment DesignCone-Beam Computed Tomographymedicine.diseaseGanglionSurgerymedicine.anatomical_structureOtorhinolaryngologyneuromodulationSurgeryOral SurgerybusinessTomography X-Ray Computed030217 neurology & neurosurgeryneurostimulation
researchProduct

Cluster headache in relation to different age groups

2019

Cluster headache (CH) has always been considered a type of primary headache affecting predominantly male subjects in early and medium adulthood. However, recent studies carried out in large case series of patients with CH show that not infrequently it may set in also after age 50; by contrast, onset before adolescence is very rare. Additionally, when onset occurs before age 14 or from the sixth decade of life onward, male predominance decreases to the point that in chronic forms CH predominantly affects the female sex. This particular pattern of the gender ratio in relation to onset in different age groups suggests that hormonal factors may actually play a role in the genesis of CH. In part…

medicine.medical_specialtyFuture studiesNeurologyEpidemiologymedicine.drug_classPhysiologyCluster HeadacheDermatology03 medical and health sciences0302 clinical medicinePrimary headacheAge groupsEpidemiologyPrevalencemedicineHumans030212 general & internal medicineAge of Onsetbusiness.industryCluster headacheAge FactorsAge at onsetGeneral Medicinemedicine.diseasePsychiatry and Mental healthEstrogenChronic DiseaseDisease ProgressionNeurology (clinical)businessBiomarkers030217 neurology & neurosurgerySex ratioNeurological Sciences
researchProduct

Migraine and cluster headache – the common link

2018

Abstract Although clinically distinguishable, migraine and cluster headache share prominent features such as unilateral pain, common pharmacological triggers such glyceryl trinitrate, histamine, calcitonin gene-related peptide (CGRP) and response to triptans and neuromodulation. Recent data also suggest efficacy of anti CGRP monoclonal antibodies in both migraine and cluster headache. While exact mechanisms behind both disorders remain to be fully understood, the trigeminovascular system represents one possible common pathophysiological pathway and network of both disorders. Here, we review past and current literature shedding light on similarities and differences in phenotype, heritability…

medicine.medical_specialtyNeurologyCluster headacheImplantable Neurostimulators/statistics & numerical dataPain medicineCalcitonin Gene-Related PeptideDeep Brain StimulationMigraine DisordersNitroglycerin/adverse effectsHypothalamuslcsh:MedicineTriptansReviewCalcitonin gene-related peptideBioinformatics03 medical and health sciencesNitroglycerin0302 clinical medicinemedicineHumans030212 general & internal medicineTryptamines/pharmacologyMigraineTrigeminovascular systembusiness.industryNeuromodulationCluster Headache/bloodCluster headacheAnti-CGRP (receptor) monoclonal antibodies – mAbsMigraine Disorders/bloodTrigeminovascular systemlcsh:RGeneral MedicineCalcitonin gene-related peptide (CGRP)medicine.diseaseDeep Brain Stimulation/statistics & numerical dataNeuromodulation (medicine)Tryptamines3. Good healthCalcitonin Gene-Related Peptide/antagonists & inhibitorsAnesthesiology and Pain MedicineImplantable NeurostimulatorsMigraineNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugThe Journal of Headache and Pain
researchProduct

EHMTI-0220. Cortical excitability in episodic cluster headache.

2014

Methods Twenty-five patients with episodic CH and thirteen healthy subjects underwent an experimental session where we evaluated, in both hemispheres, motor-cortical response to: 1) single-pulse TMS: i.e. motor threshold (MT); input-output (IO) curves and cortical silent period (CSP) and 2) paired-pulse TMS: i.e. intracortical facilitation (ICF) and short intracortical inhibition (SICI). Thirteen patients were evaluated outside bout, while the remaining twelve patients were inside bout at the time of recording.

medicine.medical_specialtyNeurologybusiness.industrymusculoskeletal neural and ocular physiologyCluster headachemedicine.medical_treatmentHealthy subjectsGeneral MedicineAudiologymedicine.diseaseTranscranial magnetic stimulationAnesthesiology and Pain MedicineIntracortical facilitationEpisodic cluster headacheMeeting AbstractmedicineIntracortical inhibitionSilent periodNeurology (clinical)businesshuman activitiesNeuroscience
researchProduct

Stimulation of the sphenopalatine ganglion (SPG) for cluster headache (CH)-/INS;pathway CH-1 — /INS;Effectiveness and quality of life through 18 mont…

2013

medicine.medical_specialtybusiness.industryCluster headacheStimulationmedicine.diseaseSurgeryGanglionmedicine.anatomical_structureNeurologyQuality of lifeAnesthesiamedicineNeurology (clinical)businessJournal of the Neurological Sciences
researchProduct

Pathway CH-1 Study: Sphenopalatine Ganglion (SPG) Stimulation for Acute Treatment of Chronic Cluster Headache (CCH) - Initial Experience (S36.002)

2012

Objective: We aimed to investigate the safety and efficacy of SPG stimulation for the acute treatment of CCH. Background The pain and autonomic symptoms of cluster headache result from activation of the trigeminal parasympathetic reflex, mediated through the SPG. Design/Methods: A multi-center, dose range finding, multiple headache attack (HA), acute treatment study with random insertion of placebo has been initiated. All subjects meet the ICHD-II criteria for CCH with a minimum of 4 HAs/week. Subjects are implanted with a miniaturized neurostimulator which, along with a controller, provides SPG stimulation. Prior to the randomized period, stimulation parameters are adjusted in a titration …

medicine.medical_specialtybusiness.industryCluster headacheStock optionsStimulationmedicine.diseasePlaceboRange findingGanglionmedicine.anatomical_structureAnesthesiamedicinePhysical therapyReflexAutonomic symptomsNeurology (clinical)businessNeurology
researchProduct